Profit at a glance
+15%
Sales from continuing operations
versus 2021, with organic sales +8% in Health, Nutrition & Bioscience
+1%
Adjusted EBITDA from continuing operations
versus 2021, with Health, Nutrition & Bioscience +2%
€310
Adjusted net operating free cash flow from continuing operations,
-50% versus 2021
€555
